Jamie Christensen - 02 Dec 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Dec 2022
Net transactions value
-$155,667
Form type
4
Filing time
05 Dec 2022, 16:00:18 UTC
Previous filing
09 Sep 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $155,667 -1,726 -1.6% $90.19 104,482 02 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on January 21, 2021.
F2 Includes 119 shares acquired under the ESPP Purchase on 11/30/2022